查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1744783

全球機械循環支援設備市場

Mechanical Circulatory Support Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 284 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球機械循環支援設備市場規模將達到 14 億美元

全球機械循環輔助裝置市場規模預計在2024年為12億美元，到2030年將達到14億美元，在2024-2030年的分析期間內，複合年成長率為3.1%。心室輔助裝置是本報告分析的細分市場之一，預計其複合年成長率為2.3%，到分析期結束時市場規模將達到6.48億美元。體外膜氧氣療法細分市場在分析期間的複合年成長率估計為4.4%。

美國市場規模估計為 3.192 億美元，而中國市場預計複合年成長率為 5.7%

美國機械循環支援設備市場規模預計在2024年達到3.192億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到2.747億美元，在分析期間（2024-2030年）的複合年成長率為5.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.3%和2.3%。在歐洲，預計德國市場的複合年成長率為1.7%。

全球機械循環支援設備市場－主要趨勢與促進因素摘要

為什麼機械循環支持將徹底改變心臟衰竭治療

機械循環支持 (MCS) 是一項挽救生命的技術，旨在支持或取代晚期心臟衰竭患者衰竭心臟的泵血功能。這些設備包括心室輔助裝置 (VAD)、全人工心臟 (TAH) 和體外膜氧氣療法(ECMO) 系統，可作為移植前的過渡、復健前的過渡，或在藥物治療無效時作為目標導向治療。 ECMO 在提高生存率、穩定危重患者病情以及改善等待心臟移植或治療不可逆性心臟衰竭的患者的生活品質方面發揮著重要作用。

微型化、生物相容性和長期植入性等技術進步，擴大了 MCS 在不同年齡層和併發症患者的應用範圍。對於合格移植的末期心臟衰竭患者，MCS 提供了一種可行的長期治療方案，可維持循環功能並改善活動能力和獨立性。人口老化以及心肌病導致的缺血性心臟疾病和心臟衰竭盛行率的上升，正在推動全球對 MCS 技術的臨床需求。

工程進步和臨床整合如何提高設備效用？

機械和材料工程領域的最新趨勢正在推動下一代輔助人工心臟的開發，這些裝置更小、更耐用，並且不易出現血栓症、出血和感染疾病等併發症。持續流動泵、磁浮和無線能量傳輸系統正在透過改善血流動力學穩定性並減輕手術負擔來重新定義患者預後。穿戴式動力傳動系統和完全植入式原型正在改善患者的活動能力和生活品質，促進門診管理和長期使用。

臨床上，即時血流動力學監測、遠端遙測和人工智慧驅動數據解讀的整合正在增強決策能力和植入後護理。由外科醫生、循環系統和復健專家組成的多學科心臟衰竭團隊，在先進的影像和風險分層工具的支持下，實施針對患者的客製化 MCS通訊協定。這些系統性改善縮短了住院時間，改善了復健效果，並使其在全球三級醫療中心日益廣泛的應用。

哪些醫療機構和病患群體正在引領採用？

心胸外科中心、學術醫院和晚期心臟衰竭計畫是 MCS 設備的主要採用者。在心臟移植計畫較為完善的美國、歐洲和日本，MCS 設備在移植前和移植後照護的使用正在增加。兒科心臟中心正在採用專為先天性心臟疾病和兒科心肌病設計的微型 MCS 系統，而新興國家則在重症監護病房引入 ECMO 系統，用於治療可逆性心臟衰竭和呼吸衰竭。

急診和創傷治療的需求也在成長，在這些情況下，可攜式膜氧合 (ECMO) 裝置被部署用於支持心臟麻痹患者並銜接關鍵干預措施。世界各地的心臟外科項目，尤其是高所得國家的心臟外科項目，正在加大對機械支持系統 (MCS) 的投資，將其作為心血管綜合護理策略的一部分。隨著心臟衰竭成為全球發病和死亡的主要原因，預計各種醫療保健機構對機械支援設備的需求都將增加。

機械循環支持市場的成長受到多種因素的推動…

機械循環支持市場的成長動力源於慢性和終末期心臟衰竭盛行率的不斷上升、設備小型化的進步，以及輔助人工心臟和體外膜氧合（ECMO）在移植和重症加護中的臨床應用日益增多。等待心臟移植的患者數量不斷增加，加上捐贈器官的短缺，推動了對長期機械支持的需求。臨床指引擴大推薦早期療育，而改進的患者選擇和出院後通訊協定也正在改善患者的預後。

對生物相容性材料、無線供電系統和完全植入式設備的投資正在推動創新，而醫療保健系統正在為心臟衰竭管理基礎設施配置資源。兒科心臟病學和創傷護理領域的新興應用也正在推動新的使用案例。此外，政府資助、FDA 早期臨床試驗資格認定以及產學研合作正在加速產品開發流程，確保 MCS 技術在全球市場的長期擴張。

部分

產品（輔助人工心臟輸液設備、體外膜氧合器、主動脈內球囊幫浦、人工心臟）；最終用途（醫院、心臟中心、門診手術中心、專科中心）

受訪公司範例（總合41家）

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets Srl
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）預測公司競爭地位的變化，我們的新報告也納入了關稅對地域市場的影響。這種複雜且多方面的市場動態預計將以人為提高銷貨成本、降低盈利、重組供應鏈等形式對競爭對手產生影響，並帶來其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶也將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP35334

Global Mechanical Circulatory Support Devices Market to Reach US$1.4 Billion by 2030

The global market for Mechanical Circulatory Support Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Ventricular Assist Devices, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$648.0 Million by the end of the analysis period. Growth in the Extracorporeal Membrane Oxygenation segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$319.2 Million While China is Forecast to Grow at 5.7% CAGR

The Mechanical Circulatory Support Devices market in the U.S. is estimated at US$319.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$274.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Mechanical Circulatory Support Devices Market - Key Trends & Drivers Summarized

Why Are Mechanical Circulatory Support Devices Revolutionizing Heart Failure Treatment?

Mechanical circulatory support (MCS) devices are life-saving technologies designed to support or replace the pumping function of the failing heart in patients with advanced heart failure. These devices-including ventricular assist devices (VADs), total artificial hearts (TAHs), and extracorporeal membrane oxygenation (ECMO) systems-are used as bridge-to-transplant, bridge-to-recovery, or destination therapy in cases where pharmacologic management is no longer sufficient. They play a crucial role in improving survival rates, stabilizing patients during critical periods, and enhancing quality of life for those awaiting cardiac transplants or managing irreversible cardiac decline.

Advances in miniaturization, biocompatibility, and long-term implantability have expanded the indications for MCS use across age groups and comorbidities. For end-stage heart failure patients ineligible for transplant, MCS devices offer a viable long-term treatment option that sustains circulatory function and improves mobility and independence. The increasing prevalence of heart failure due to aging populations, ischemic heart disease, and cardiomyopathies is driving the global clinical demand for MCS technologies.

How Are Engineering Advances and Clinical Integration Enhancing Device Utility?

Recent innovations in mechanical and materials engineering have led to the development of next-generation VADs that are smaller, more durable, and less prone to complications like thrombosis, bleeding, or infection. Continuous-flow pumps, magnetically levitated impellers, and wireless energy transfer systems are redefining patient outcomes by improving hemodynamic stability with reduced surgical burden. Wearable driveline systems and fully implantable prototypes are improving patient mobility and quality of life, facilitating outpatient management and long-term use.

On the clinical front, integration of real-time hemodynamic monitoring, remote telemetry, and AI-assisted data interpretation is enhancing decision-making and post-implantation care. Multidisciplinary heart failure teams, including surgeons, cardiologists, and rehabilitation specialists, are implementing patient-tailored MCS protocols supported by advanced imaging and risk stratification tools. These systemic improvements are reducing hospitalization time, improving recovery outcomes, and expanding adoption in tertiary care centers worldwide.

Which Healthcare Settings and Patient Segments Are Leading Adoption?

Cardiothoracic surgical centers, academic hospitals, and advanced heart failure programs are the primary adopters of MCS devices. In the U.S., Europe, and Japan, where cardiac transplant programs are well established, MCS devices are increasingly used as both pre-transplant and destination therapy. Pediatric cardiac centers are adopting miniaturized MCS systems designed for congenital heart disease and pediatric cardiomyopathies, while emerging economies are deploying ECMO systems in critical care units for reversible cardiac or respiratory failure.

Demand is also growing in emergency and trauma settings, where portable ECMO units are deployed to support cardiac arrest patients or bridge critical interventions. Global cardiac surgery programs, especially in high-income nations, are investing in MCS as part of integrated cardiovascular care strategies. As heart failure becomes a leading cause of morbidity and mortality worldwide, demand for mechanical support devices is expected to rise across a broad spectrum of care settings.

The Growth in the Mechanical Circulatory Support Devices Market Is Driven by Several Factors…

The growth in the mechanical circulatory support devices market is driven by increasing prevalence of chronic and end-stage heart failure, advances in device miniaturization, and expanded clinical adoption of VADs and ECMO in transplant and critical care. Rising numbers of patients awaiting heart transplants, coupled with donor organ shortages, are fueling demand for long-term mechanical support. Clinical guidelines are increasingly endorsing early intervention with MCS, while better patient selection and post-discharge protocols are improving outcomes.

Investments in biocompatible materials, wireless power systems, and fully implantable devices are driving innovation, while healthcare systems are allocating resources to heart failure management infrastructure. Emerging applications in pediatric cardiology and trauma care are also creating new use cases. Furthermore, government funding, FDA fast-track designations, and academic-industry partnerships are accelerating product development pipelines-ensuring long-term global market expansion for MCS technologies.

SCOPE OF STUDY:

The report analyzes the Mechanical Circulatory Support Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps, Artificial Heart); End-Use (Hospitals, Cardiology Centers, Ambulatory Surgery Centers, Specialty Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • BiVACOR Inc.
  • Braile Biomedica Ltd.
  • CardiacAssist, Inc.
  • CardioBridge GmbH
  • Carmat SA
  • Eurosets S.r.l.
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • MicroMed Cardiovascular, Inc.
  • ReliantHeart, Inc.
  • St. Jude Medical, Inc.
  • Sun Medical Technology Research Corp.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corporation

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Mechanical Circulatory Support Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of End-Stage Heart Failure Globally Drives Demand for Mechanical Circulatory Support (MCS) Devices
    • Growing Preference for Ventricular Assist Devices (VADs) as Bridge-to-Transplant Solutions Expands Clinical Adoption
    • Advancements in Miniaturization and Wireless Power Transfer Strengthen the Case for Next-Generation Implantable MCS Systems
    • Improved Patient Survival Rates With Long-Term LVAD Use Encourage Wider Use in Destination Therapy Applications
    • Expansion of Advanced Heart Failure Programs in Hospitals Boosts Institutional Investment in MCS Infrastructure
    • Rising Number of Heart Transplant Candidates Highlights Demand for Durable Bridge-to-Transplant Support Systems
    • OEM Focus on Fully Implantable and Percutaneous Systems Enhances Patient Mobility and Reduces Infection Risks
    • Integration of Remote Monitoring and Telehealth Capabilities Supports Post-Implant Management and Reduces Readmissions
    • Government Reimbursement Policies and Public Health Coverage Expand Patient Access to MCS Devices in Developed Markets
    • Clinical Research Demonstrating Improved Quality of Life Fuels Physician Confidence in Prescribing MCS Therapies
    • Increasing Use of MCS in Pediatric and Congenital Heart Disease Applications Creates New Niche Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mechanical Circulatory Support Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mechanical Circulatory Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Ventricular Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Ventricular Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Extracorporeal Membrane Oxygenation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Extracorporeal Membrane Oxygenation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Intra-Aortic Balloon Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Intra-Aortic Balloon Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Artificial Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Artificial Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Specialty Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Specialty Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Mechanical Circulatory Support Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Mechanical Circulatory Support Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Mechanical Circulatory Support Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Mechanical Circulatory Support Devices by Product - Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by Product - Percentage Breakdown of Value Sales for Ventricular Assist Devices, Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pumps and Artificial Heart for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Mechanical Circulatory Support Devices by End-Use - Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Mechanical Circulatory Support Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cardiology Centers, Ambulatory Surgery Centers and Specialty Centers for the Years 2015, 2025 & 2030

IV. COMPETITION